Notice Regarding Results of Tender Offer for Shares of Sogo Medical Holdings Co., Ltd.

LONDON--()-- 

This announcement is for our U.S.$5,000,000,000 Euro Medium Term Note Programme.

March 30, 2020

For Immediate Release
To Whom It May Concern

Company Name: Mitsui & Co., Ltd.
Representative: Tatsuo Yasunaga, President & CEO
(Code No.: 8031)
Head office: 1-3, Marunouchi 1-chome, Chiyoda-ku, Tokyo

Notice Regarding Results of Tender Offer for Shares of Sogo Medical Holdings Co., Ltd.

As stated in the announcement entitled “Execution of Agreement to Accept Tender Offer for Shares of Sogo Medical Holdings Co., Ltd.” dated February 5, 2020, Mitsui & Co., Ltd. (hereinafter "Mitsui" or "the Company", President and CEO: Tatsuo Yasunaga) entered into an agreement with PSM Holdings Inc. (hereinafter “PSM”) to accept PSM’s tender offer (hereinafter the “Tender Offer”) implemented through the management buy-out (MBO) of the Sogo Medical Holdings Co., Ltd. (hereinafter “Sogo”, Tokyo Stock Exchange First Section, Code No.:9277) which is Mitsui’s equity accounted investee.

Tender Offer concluded as the announcement of Sogo dated March 24, 2020. This is to provide notice that Mitsui completed the procedure of transferring its stock today and will record the gain on its sales amounting approximately to JPY 9 billion on after-tax basis for the fiscal year ending March 31, 2020. Meanwhile, the profit from this transaction was not included in Mitsui’s latest earnings forecasts announced on February 4, 2020.

For further information, please contact:

 

 

Mitsui & Co., Ltd.

Investor Relations Division

 

Tel: +81-3-3285-7657

Corporate Communications Division

 

Tel: +81-3-3285-7596

Notice:

This announcement contains forward-looking statements. These forward-looking statements are based on Mitsui's current assumptions, expectations and beliefs in light of the information currently possessed by it and involve known and unknown risks, uncertainties and other factors. Such risks, uncertainties and other factors may cause Mitsui's actual results, financial position or cash flows to be materially different from any future results, financial position or cash flows expressed or implied by these forward-looking statements. These risks, uncertainties and other factors referred to above include, but are not limited to, those contained in Mitsui's latest Annual Securities Report and Quarterly Securities Report, and Mitsui undertakes no obligation to publicly update or revise any forward-looking statements. This announcement is published in order to publicly announce specific facts stated above, and does not constitute a solicitation of investments or any similar act inside or outside of Japan, regarding the shares, bonds or other securities issued by us.

Short Name: Mitsui & Co., Ltd.
Category Code: MSCH
Sequence Number: 695989
Time of Receipt (offset from UTC): 20200330T075831+0100

Contacts

Mitsui & Co Ltd

Contacts

Mitsui & Co Ltd